tiprankstipranks
Repare Therapeutics Inc (RPTX)
NASDAQ:RPTX
US Market
Holding RPTX?
Track your performance easily

Repare Therapeutics (RPTX) Income Statement

370 Followers

Repare Therapeutics Income Statement

Last quarter (Q3 2024), Repare Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Repare Therapeutics's net income was $-34.41M. See Repare Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 65.45M$ 51.13M$ 131.83M--$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 160.27M$ 167.36M$ 151.63M$ 116.26M$ 54.44M$ 26.38M
Operating Income
$ -93.74M$ -116.22M$ -19.80M$ -108.66M$ -54.30M$ -26.38M
Net Non Operating Interest Income Expense
$ -13.33M$ -13.33M$ -5.63M-$ 240.00K$ 0.00
Other Income Expense
$ 1.59M$ -289.00K$ 265.00K$ -218.00K$ -224.00K$ -644.00K
Pretax Income
$ -82.42M$ -103.18M$ -13.90M$ -108.59M$ -54.74M$ -27.02M
Tax Provision
$ 1.63M$ -9.38M$ 15.15M$ -1.68M$ -1.32M$ 195.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -84.05M$ -93.80M$ -29.05M$ -106.91M$ -53.42M$ -27.22M
Basic EPS
$ -1.99$ -2.23$ -0.69$ -2.83$ -2.66$ -1.64
Diluted EPS
$ -2.00$ -2.23$ -0.69$ -2.83$ -2.66$ -1.64
Basic Average Shares
$ 169.27M$ 42.09M$ 41.92M$ 37.82M$ 20.05M$ 15.79M
Diluted Average Shares
$ 171.06M$ 42.09M$ 41.92M-$ 20.05M$ 15.79M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 160.27M$ 167.36M$ 151.63M$ 116.26M$ 54.44M$ 26.38M
Net Income From Continuing And Discontinued Operation
$ -84.05M$ -93.80M$ -29.05M$ -106.91M$ -53.42M$ -27.22M
Normalized Income
$ -88.15M$ -112.56M-$ -110.26M-$ -27.74M
Interest Expense
------
EBIT
$ -88.42M$ -116.22M$ -19.80M$ -108.66M$ -54.30M$ -26.38M
EBITDA
$ -83.39M$ -114.27M$ -17.82M$ -107.19M$ -53.41M$ -25.77M
Currency in USD

Repare Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis